The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,1-dimethyl-5-[[4-[3-methyl-4-[(3S)-pyrrolidin-3-yl]oxy-pyrazol-1-yl]pyrimidin-2-yl]amino]indazole-3-carboxamide ID: ALA4760470
PubChem CID: 162658022
Max Phase: Preclinical
Molecular Formula: C22H25N9O2
Molecular Weight: 447.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1nn(C)c2ccc(Nc3nccc(-n4cc(O[C@H]5CCNC5)c(C)n4)n3)cc12
Standard InChI: InChI=1S/C22H25N9O2/c1-13-18(33-15-6-8-24-11-15)12-31(28-13)19-7-9-25-22(27-19)26-14-4-5-17-16(10-14)20(21(32)23-2)29-30(17)3/h4-5,7,9-10,12,15,24H,6,8,11H2,1-3H3,(H,23,32)(H,25,26,27)/t15-/m0/s1
Standard InChI Key: DUQRGTCLMVTXDF-HNNXBMFYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
21.5468 -28.3334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5457 -29.1529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2537 -29.5619 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9634 -29.1524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9606 -28.3298 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2520 -27.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6718 -29.5599 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.3788 -29.1502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0838 -29.5581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7904 -29.1491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3726 -28.3351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0763 -27.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7857 -28.3319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3931 -27.7833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0591 -27.0360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2452 -27.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6975 -26.5165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9488 -25.7389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8984 -26.6877 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7479 -25.5678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1927 -27.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2495 -27.1073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.9097 -26.6251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6548 -25.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8376 -25.8511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5875 -26.6290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1332 -25.1861 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3552 -25.1914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7986 -24.4405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2021 -23.7297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6535 -23.1240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9079 -23.4587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9958 -24.2711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 13 2 0
12 11 2 0
11 8 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 12 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
14 21 1 0
6 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 22 1 0
24 27 1 0
25 28 1 0
29 27 1 1
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 447.50Molecular Weight (Monoisotopic): 447.2131AlogP: 1.70#Rotatable Bonds: 6Polar Surface Area: 123.81Molecular Species: BASEHBA: 10HBD: 3#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.70CX Basic pKa: 10.22CX LogP: 1.31CX LogD: -1.37Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.41Np Likeness Score: -1.43
References 1. Barlaam B,Boiko S,Boyd S,Dry H,Gingipalli L,Ikeda T,Johnson T,Kawatkar S,Lorthioir O,Pike A,Pollard H,Read J,Su Q,Wang H,Wang H,Wang L,Wang P,Edmondson SD. (2020) Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors., 30 (22): [PMID:32877741 ] [10.1016/j.bmcl.2020.127523 ]